Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose.

Authors

Amber N. Edinoff, Louisiana State University Health Shreveport
Catherine A. Nix, Louisiana State University Health Shreveport
Tanner D. Reed, LSU Health Sciences Center - New OrleansFollow
Elizabeth M. Bozner, LSU Health Sciences Center - New OrleansFollow
Mark R. Alvarez, Louisiana State University Health Shreveport
Mitchell C. Fuller, Medical College of Wisconsin, Milwaukee, WI
Fatimah Anwar, University of New Haven, West Haven, CT
Elyse M. Cornett, Louisiana State University Health Shreveport
Adam M. Kaye, University of the Pacific, Stockton, CA
Alan D. Kaye, Louisiana State University Health Shreveport

Document Type

Article

Publication Date

10-14-2021

Publication Title

Psychiatry International

First Page

365

Volume

2

Issue

4

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Edinoff, Amber N.; Nix, Catherine A.; Reed, Tanner D.; Bozner, Elizabeth M.; Alvarez, Mark R.; Fuller, Mitchell C.; Anwar, Fatimah; Cornett, Elyse M.; Kaye, Adam M.; and Kaye, Alan D., "Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose." (2021). School of Medicine Faculty Publications. 1333.
https://digitalscholar.lsuhsc.edu/som_facpubs/1333